BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28196992)

  • 1. Subtyping of alcohol dependence in Indian males: A cluster analytic approach.
    Malhotra S; Basu D; Ghosh A; Khullar M; Kakkar N
    Indian J Psychiatry; 2016; 58(4):372-377. PubMed ID: 28196992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Externalizing spectrum or spectra? Underlying dimensions of the externalizing spectrum.
    Ingole R; Ghosh A; Malhotra S; Basu D
    Asian J Psychiatr; 2015 Jun; 15():25-31. PubMed ID: 26003778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between ADHD and Antisocial Personality Disorder (ASPD): A Review.
    Storebø OJ; Simonsen E
    J Atten Disord; 2016 Oct; 20(10):815-24. PubMed ID: 24284138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parent personality traits and psychopathology associated with antisocial behaviors in childhood attention-deficit hyperactivity disorder.
    Nigg JT; Hinshaw SP
    J Child Psychol Psychiatry; 1998 Feb; 39(2):145-59. PubMed ID: 9669228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are childhood externalizing disorders the harbinger of early-onset alcohol dependence?
    Ghosh A; Malhotra S; Basu D
    Indian J Med Res; 2016 Sep; 144(3):385-392. PubMed ID: 28139537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Externalizing disorders in American Indians: comorbidity and a genome wide linkage analysis.
    Ehlers CL; Gilder DA; Slutske WS; Lind PA; Wilhelmsen KC
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):690-8. PubMed ID: 18286631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD.
    Biederman J; Faraone SV; Milberger S; Jetton JG; Chen L; Mick E; Greene RW; Russell RL
    J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1193-204. PubMed ID: 8824063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood antecedents of adult violent offending in a group of female felons.
    Lewis CF
    Behav Sci Law; 2010; 28(2):224-34. PubMed ID: 20422647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
    Pringsheim T; Hirsch L; Gardner D; Gorman DA
    Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response inhibition deficits in externalizing child psychiatric disorders: an ERP-study with the Stop-task.
    Albrecht B; Banaschewski T; Brandeis D; Heinrich H; Rothenberger A
    Behav Brain Funct; 2005 Dec; 1():22. PubMed ID: 16336676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisocial personality disorder with childhood- vs. adolescence-onset conduct disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Goldstein RB; Grant BF; Ruan WJ; Smith SM; Saha TD
    J Nerv Ment Dis; 2006 Sep; 194(9):667-75. PubMed ID: 16971818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personality characteristics of ADHD adults assessed with the Millon Clinical Multiaxial Inventory-II: evidence of four distinct subtypes.
    May B; Bos J
    J Pers Assess; 2000 Oct; 75(2):237-48. PubMed ID: 11020142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liberal alcohol legislation: does it amplify the effects among Swiss men of person-related risk factors on heavy alcohol use?
    Foster S; Held L; Estévez N; Gmel G; Mohler-Kuo M
    Addiction; 2015 Nov; 110(11):1746-56. PubMed ID: 26219733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replicated association of Synaptotagmin (SYT1) with ADHD and its broader influence in externalizing behaviors.
    Cupertino RB; Schuch JB; Bandeira CE; da Silva BS; Rovaris DL; Kappel DB; Contini V; Salatino-Oliveira A; Vitola ES; Karam RG; Hutz MH; Rohde LA; Grevet EH; Bau CHD; Mota NR
    Eur Neuropsychopharmacol; 2017 Mar; 27(3):239-247. PubMed ID: 28130000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.